Phase I AZD2281/Cisplatin in Advanced Solid Tumour Patients

NCT00782574 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: AZD2281
DRUG: Cisplatin

Sponsor

AstraZeneca